CD 34 - STEM CELL ENUMERATION
Get reliable diagnostics, expert support, and a seamless booking experience with Focus Diagnostics.
About this test
The CD34 Stem Cell Enumeration Test is an advanced laboratory test used to measure the number of CD34-positive hematopoietic stem cells present in peripheral blood, bone marrow, or stem cell collection products. The test is typically performed using flow cytometry, a highly specialized technology that accurately identifies and quantifies stem cells based on the presence of the CD34 surface marker.
CD34 is a protein expressed on the surface of hematopoietic stem and progenitor cells. These cells are responsible for generating all types of blood cells, including red blood cells, white blood cells, and platelets. Measuring the concentration of CD34-positive cells is essential for assessing stem cell mobilization and determining whether an adequate number of stem cells have been collected for transplantation.
This test plays a vital role in bone marrow transplantation, autologous stem cell transplantation, and allogeneic stem cell transplantation. It helps clinicians determine the optimal timing for stem cell collection and evaluate the quality of stem cell harvests.
Benefits of the Test
- Accurately measures hematopoietic stem cell levels
- Helps assess stem cell mobilization success
- Supports stem cell transplantation planning
- Evaluates adequacy of stem cell collection
- Assists transplant specialists in treatment decisions
- Improves the likelihood of successful transplantation
Why Doctors Recommend This Test
Doctors commonly recommend CD34 Stem Cell Enumeration for:
- Stem cell transplantation planning
- Monitoring stem cell mobilization therapy
- Evaluation of stem cell collection procedures
- Bone marrow transplant preparation
- Leukemia treatment planning
- Lymphoma management
- Multiple myeloma treatment programs
- Donor stem cell assessment
The test helps ensure that sufficient stem cells are available before transplantation is performed.
Preparation Before Test
Preparation depends on the clinical situation and transplant protocol.
- No fasting is usually required
- Inform your doctor about medications and treatments
- Follow instructions regarding stem cell mobilization injections if applicable
- Attend scheduled blood sample collections as advised
Samples may be collected from peripheral blood, bone marrow, or harvested stem cell products.
Normal Reporting Time
Results are generally available within 24 hours, although urgent transplant-related testing may be reported on the same day.
Who Should Take This Test?
- Patients undergoing stem cell transplantation
- Individuals with leukemia
- Patients with lymphoma
- Multiple myeloma patients
- Stem cell donors
- Individuals receiving stem cell mobilization therapy
- Patients requiring bone marrow transplantation
The CD34 Stem Cell Enumeration Test is a critical tool in transplant medicine and helps optimize stem cell collection and transplantation outcomes.
Clinical Significance
The test is commonly used in:
- Autologous stem cell transplantation
- Allogeneic stem cell transplantation
- Hematopoietic stem cell transplantation
- Leukemia treatment
- Lymphoma management
- Multiple myeloma therapy
- Bone marrow failure syndrome evaluation
Higher CD34-positive cell counts generally indicate successful stem cell mobilization and adequate stem cell availability for transplantation. Low counts may indicate the need for additional mobilization therapy or further collection procedures.
Test FAQs
What is the CD34 Stem Cell Enumeration Test?
What are CD34-positive cells?
Why is this test important?
How is the test performed?
Is fasting required?
Who commonly needs this test?
What sample is required?
How long does it take to get results?
Is this test used in cancer treatment?
Who interprets the results?
Find Your Nearest Focus Diagnostic Centre Hyderabad
Popular Lab Tests in Other Cities
Telangana
Andhra Pradesh
Book Your lab tests instantly
Accurate reports and home sample collection across Hyderabad
@2025 Focus Diagnostic & Healthcare Research Private Limited. All rights reserved